Is there a race-based disparity in the survival of veterans with HIV?

Giordano TP, Morgan RO, Kramer JR, Hartman C, Richardson P, White CA, Suarez-Almazor ME, El-Serag HB. Is there a race-based disparity in the survival of veterans with HIV? Journal of general internal medicine. 2006 Jun 1; 21(6):613-7.

Related HSR&D Project(s)

• IIR 02-293 – Outcomes of Veterans with Dual HCV-HIV Infection

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.    Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions

Search for Abstract from PubMed

---

Abstract:

BACKGROUND: Disparities in survival for black patients with HIV in the United States have been reported. The VA is an equal access health care system. OBJECTIVE: To determine whether such disparities are present in the VA health care system. DESIGN: Retrospective cohort study using national VA administrative databases. PATIENTS: Two thousand three hundred and four white and 3,641 black HIV-infected patients first hospitalized for HIV between October 1, 1996 and September 30, 2000. MEASUREMENTS: Thirty-day mortality after first hospitalization with HIV, and subsequent long-term survival. Follow-up ended at death or September 30, 2002. Data were adjusted for age, sex, HIV disease severity, non-HIV-related comorbidities, primary discharge diagnosis, hepatitis C status, and facility effects. RESULTS: The mean follow-up was 3.2 years. Overall survival was similar for black patients compared with white patients (adjusted hazard ratio 1.09, P = .09). Hospital mortality was 7.0% for black and 6.4% for white patients (P = .35). Adjusted hospital mortality for black patients was similar to that of white patients (odds ratio 1.20, P = .10). Long-term survival after hospitalization did not significantly differ by race (adjusted hazard ratio 1.07, P = .21, for black patients compared with white patients). CONCLUSIONS: Survival during and after first hospitalization with HIV in the VA did not significantly differ for white and black patients, possibly indicating similar effectiveness of care for HIV. Further research is needed to understand the reasons for the lack of disparities for VA patients with HIV and whether the VA's results could be replicated.